WERNER ROBERT F. 4

What Happened

• Robert F. Werner, Chief Accounting Officer of Twist Bioscience (TWST), sold 4,961 shares in an open-market transaction on May 8, 2026.
• The shares were sold at $56.88 per share for a total transaction value of $282,187. This was a sale (not a purchase), which is generally considered routine insider selling rather than a bullish signal.

Key Details

• Transaction date: 2026-05-08
• Transaction type/code: Open-market sale (S)
• Price and amount: 4,961 shares at $56.88 each; total proceeds $282,187
• Shares owned after transaction: Not specified in the provided filing excerpt (see the full Form 4 for post-transaction holdings)
• Footnotes/plan details: No 10b5-1 plan, tax-withholding, or other footnotes disclosed in the summary provided
• Filing timeliness: Form 4 filed on 2026-05-12, which is within the SEC’s two-business-day filing window for a May 8 transaction

Context

• Sales by executives can reflect many reasons (diversification, liquidity needs, planned selling) and are not by themselves a clear signal of company outlook; purchases generally carry more weight for signaling confidence.
• This was a straightforward open-market sale of existing shares (no option exercise or cashless transaction was reported in the provided details).